524 related articles for article (PubMed ID: 17029990)
1. Granulocyte and granulocyte macrophage colony-stimulating factors as therapy in human and veterinary medicine.
Fernández-Varón E; Villamayor L
Vet J; 2007 Jul; 174(1):33-41. PubMed ID: 17029990
[TBL] [Abstract][Full Text] [Related]
2. Colony-stimulating factors in veterinary medicine: an unexplored potential.
Mobasheri A
Vet J; 2007 Jul; 174(1):8-9. PubMed ID: 17029880
[No Abstract] [Full Text] [Related]
3. Prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor decrease febrile neutropenia after chemotherapy in children with cancer: a meta-analysis of randomized controlled trials.
Sung L; Nathan PC; Lange B; Beyene J; Buchanan GR
J Clin Oncol; 2004 Aug; 22(16):3350-6. PubMed ID: 15310780
[TBL] [Abstract][Full Text] [Related]
4. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
Wong SF; Chan HO
Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
[TBL] [Abstract][Full Text] [Related]
5. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: comparisons and potential for use in the treatment of infections in nonneutropenic patients.
Root RK; Dale DC
J Infect Dis; 1999 Mar; 179 Suppl 2():S342-52. PubMed ID: 10081506
[TBL] [Abstract][Full Text] [Related]
6. Granulocyte, granulocyte-macrophage, and macrophage colony-stimulating factors can stimulate the invasive capacity of human lung cancer cells.
Pei XH; Nakanishi Y; Takayama K; Bai F; Hara N
Br J Cancer; 1999 Jan; 79(1):40-6. PubMed ID: 10408691
[TBL] [Abstract][Full Text] [Related]
7. Hematopoietic growth factors in the reduction of chemotherapeutic toxicity.
Johnston EM; Crawford J
Semin Oncol; 1998 Oct; 25(5):552-61. PubMed ID: 9783594
[TBL] [Abstract][Full Text] [Related]
8. Regulation of myeloid development and function by colony stimulating factors.
Barreda DR; Hanington PC; Belosevic M
Dev Comp Immunol; 2004 May; 28(5):509-54. PubMed ID: 15062647
[TBL] [Abstract][Full Text] [Related]
9. Increased levels of multiple forms of dihydrofolate reductase in peripheral blood leucocytes of cancer patients receiving haematopoietic colony-stimulating factors: interim analysis.
Iqbal MP; Burney IA; Sultana F; Mehboobali N; Siddiqui T
Exp Mol Med; 2000 Jun; 32(2):84-7. PubMed ID: 10926120
[TBL] [Abstract][Full Text] [Related]
10. Colony-stimulating factors in the prevention and management of infectious diseases.
Page AV; Liles WC
Infect Dis Clin North Am; 2011 Dec; 25(4):803-17. PubMed ID: 22054757
[TBL] [Abstract][Full Text] [Related]
11. Hematopoietic management in oncology practice. Part 1. Myeloid growth factors.
Glaspy JA
Oncology (Williston Park); 2003 Nov; 17(11):1593-603. PubMed ID: 14682110
[TBL] [Abstract][Full Text] [Related]
12. Clinical effects of biologic response modifiers.
Louie SG; Jung B
Am J Hosp Pharm; 1993 Jul; 50(7 Suppl 3):S10-8. PubMed ID: 7689788
[TBL] [Abstract][Full Text] [Related]
13. [Biology and clinical applications of GM-CSF].
Robak T
Acta Haematol Pol; 1994; 25(2):99-109. PubMed ID: 8067193
[TBL] [Abstract][Full Text] [Related]
14. Current status of growth factors in the treatment of acute myeloid and lymphoblastic leukemia.
Ottmann OG; Bug G; Krauter J
Semin Hematol; 2007 Jul; 44(3):183-92. PubMed ID: 17631182
[TBL] [Abstract][Full Text] [Related]
15. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor promote malignant growth of cells from head and neck squamous cell carcinomas in vivo.
Gutschalk CM; Herold-Mende CC; Fusenig NE; Mueller MM
Cancer Res; 2006 Aug; 66(16):8026-36. PubMed ID: 16912178
[TBL] [Abstract][Full Text] [Related]
16. Effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on neutrophil formation and function.
Khwaja A; Linch DC
Curr Opin Hematol; 1994 May; 1(3):216-20. PubMed ID: 9371285
[TBL] [Abstract][Full Text] [Related]
17. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
Hershman D; Neugut AI; Jacobson JS; Wang J; Tsai WY; McBride R; Bennett CL; Grann VR
J Natl Cancer Inst; 2007 Feb; 99(3):196-205. PubMed ID: 17284714
[TBL] [Abstract][Full Text] [Related]
18. [Report on the current indications for colony stimulating factors (G-CSF and GM-CSF)].
Med Clin (Barc); 1994 May; 102(19):747-50. PubMed ID: 7518884
[No Abstract] [Full Text] [Related]
19. The role of colony-stimulating factors and granulocyte transfusion in treatment options for neutropenia in children with cancer.
Liang DC
Paediatr Drugs; 2003; 5(10):673-84. PubMed ID: 14510625
[TBL] [Abstract][Full Text] [Related]
20. Effect of granulocyte colony-stimulating factor on granulopoiesis of congenital neutropenic children.
Benkö I; Maródi L; Megyeri A; Káposzta R; Kovács P
Acta Physiol Hung; 1996; 84(3):261-2. PubMed ID: 9219597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
